Wetsontwerp betreffende klinische proeven met geneesmiddelen voor menselijk gebruik.

This bill aims to update the rules for conducting clinical trials with medicines intended for human use. It ensures that these trials are carried out safely and ethically, protecting the rights and well-being of participants. The legislation affects patients involved in trials, researchers, pharmaceutical companies, and regulatory authorities. It aligns Belgian law with EU directives, promoting harmonized standards for medical research across Europe.